Your browser doesn't support javascript.
loading
Toripalimab Combined With Hepatic Arterial Infusion Chemotherapy Versus Lenvatinib for Advanced Hepatocellular Carcinoma.
Xu, Yu-Jie; Lai, Zhi-Cheng; He, Min-Ke; Bu, Xiao-Yun; Chen, Huan-Wei; Zhou, Yuan-Min; Xu, Li; Wei, Wei; Zhang, Yao-Jun; Chen, Min-Shan; Guo, Rong-Ping; Shi, Ming; Li, Qi-Jiong.
Afiliación
  • Xu YJ; 71067Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Lai ZC; 71067Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • He MK; 71067Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Bu XY; 71067Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Chen HW; 66278First People's Hospital of Foshan, Foshan, China.
  • Zhou YM; 560901Guangzhou No. 12 People's Hospital, Guangzhou, China.
  • Xu L; 71067Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Wei W; 71067Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Zhang YJ; 71067Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Chen MS; 71067Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Guo RP; 71067Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Shi M; 71067Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
  • Li QJ; 71067Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Technol Cancer Res Treat ; 20: 15330338211063848, 2021.
Article en En | MEDLINE | ID: mdl-34898313
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Quinolinas / Quimioembolización Terapéutica / Carcinoma Hepatocelular / Inhibidores de Proteínas Quinasas / Anticuerpos Monoclonales Humanizados / Inhibidores de Puntos de Control Inmunológico / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Technol Cancer Res Treat Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Compuestos de Fenilurea / Quinolinas / Quimioembolización Terapéutica / Carcinoma Hepatocelular / Inhibidores de Proteínas Quinasas / Anticuerpos Monoclonales Humanizados / Inhibidores de Puntos de Control Inmunológico / Neoplasias Hepáticas Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Technol Cancer Res Treat Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos